Spectrum and subcellular determinants of fluorinated anesthetic-mediated proximal tubular injury

American Journal of Pathology

Volumn 150, Issue 6, 1997, Pages 2209-2221

  Lochhead, Karen M ^a   Kharasch, Evan D ^a   Zager, Richard A ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; DESFLURANE; ISOFLURANE; METHOXYFLURANE; SEVOFLURANE;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; DOSE RESPONSE; DRUG EFFECT; HUMAN; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING;

ACETYLGLUCOSAMINIDASE; ADENINE NUCLEOTIDES; ADULT; AGED; ANESTHETICS, INHALATION; ANIMALS; CREATININE; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ETHER, ETHYL; ETHERS; FLUORIDES; HUMANS; ISOFLURANE; KIDNEY TUBULES, PROXIMAL; L-LACTATE DEHYDROGENASE; MALE; METHYL ETHERS; MIDDLE AGED; OUABAIN; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031006879     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kellerman PS: Perioperative care of the renal patient. Arch Int Med 1994, 154:1674-168
2. Novis BK, Roizen MF, Aronson S, Thisted RA: Association of preoperative risk factors with postoperative acute renal failure. Anesth Analg 1994, 8:143-149
3. Marshall BE, Longnecker DE: General anesthetics, Goodman and Gilman's The Pharmacologic Basis of Therapeutics, ed 9. New York, McGraw-Hill, 1996, pp 307-330
4. Zager RA: Gentamicin nephrotoxicity in the setting of acute renal hypoperfusion. Am J Physiol 1988, 254: F574-F581
5. Zager RA: Myoglobin depletes renal adenine nucleotide pools in the presence and absence of shock. Kidney Int 1991, 39:111-119
6. Hollenberg NK, McDonald FD, Cotran R, Galvanek EG, Wahol M, Vandam LD, Merrill JP: Irreversible acute oliguric renal failure: a complication of methoxyflurane anesthesia. N Engl J Med 1972, 286:877-879
7. Crandall WB, Pappas SG, McDonald A: Nephrotoxicity associated with methoxyflurane anesthesia. Anesthesiology 1966, 27:591-607
8. Panner BJ, Freeman RB, Roth-Moyo LA, Markowitch W: Toxicity following methoxyflurane anesthesia. JAMA 1970, 214:86-90
9. Mazze RI, Shue GL, Jackson SH: Renal dysfunction following methoxyflurane anesthesia. JAMA 1971, 216:278-288
10. Taves DR, Fry BW, Freeman RB, Gillies AJ: Toxicity of methoxyflurane anesthesia. JAMA 1970, 214:91-95
11. Mazze RI, Trudell JR, Cousins MJ: Methoxyflurane metabolism and renal dysfunction. Anesthesiology 1971, 35:247-252
12. Mazze RI, Calverley RK, Smith NT: Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. Anesthesiology 1977, 46:265-271
13. Kharasch ED: Biotransformation of sevoflurane. Anesth Analg 1995, 81:S27-S38
14. Whitford GM: The metabolism and toxicity of fluoride. Monographs in Oral Science, vol 13. Basel, Karger, 1989, pp 1-160
15. Zager RA, Iwata M: Inorganic fluoride: divergent effects on human proximal tubular cell viability. Am J Pathol 1997, 150:734-745
16. Kharasch ED, Hankins DC, Thummel KE: Human kidney methoxyflurane and sevoflurane metabolism. Anesthesiology 1995, 82:689-699
17. Kharasch ED, Thummel KE: Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevofiurane, isoflurane, and methoxyflurane. Anesthesiology 1993, 79:795-807
18. Kharasch ED, Thummel KE, Mautx D, Bosse S: Clinical enflurane metabolism by cytochrome P450 2E1. Clin Pharmacol Ther 1994, 55:434-440
19. Zager RA, Sharma HM, Johannes GA: Gentamicin increases renal susceptibility to an acute ischemic insult. J Lab Clin Med 1983, 101:670-678
20. Zager RA, Prior RB: Gentamicin and gram negative bacteremia: a synergism for the development of experimental nephrotoxic acute renal failure. J Clin Invest 1986, 78:196-204
21. Zager RA, Gamelin LM: Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. Am J Physiol 1989, 256:F446-F455
22. Zager RA, Gmur DJ, Bredl CR, Eng MJ: Temperature effects on ischemic and hypoxic renal proximal tubular injury. Lab Invest 1991, 64:766-776
23. 2: a potentially important determinant of adenosine triphosphate levels during hypoxic-reoxygenation tubular injury. J Am Soc Nephrol 1996, 7:2327-2339
24. Brady HR, Kone BC, Stromski ME, Zeidel ML, Giebisch G, Gullans SR: Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am J Physiol 1990, 258:F1181-1187
25. 1 cells. Pharmacology 1995, 50:348-356
26. Mugford DA, Tarloff JB: Contribution of oxidation and deacetylation to the bioactivation of acetaminophen in vitro in liver and kidney from male and female Sprague Dawley rats. Drug Metab Dispos 1995, 23:290-294
27. Knickle LC, Webb CD, House AA, Bend JR: Mechanism based inactivation of cytochrome P450 by N-aralkyl-l-aminobenzotriazole in Guinea pig kidney in vivo and in vitro. J Pharmacol Exp Ther 1993, 267:758-764
28. Palmieri L, Ronca G, Cioni L, Puccini R: Enzymuria as a marker of renal injury and disease: studies of N-acetyl-β-glucosaminidase, alanine aminopeptidase, and lysozyme in patients with renal disease. Contrib Nephrol 1984, 42:123-129
29. Burdmann EA, Andoh TF, Lindsley J, Russell J, Bennett WM, Porter G: Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs. Renal Failure 1994, 16:161-168
30. Fink JC, Cooper MA, Burkhart KM, McDonald GB, Zager RA: Marked enzymuria after bone marrow transplantation: a correlate of veno-occlusive disease-induced hepatorenal syndrome. J Am Soc Nephrol 1995, 6:1655-1660
31. Kharasch ED, Karol MD, Lanni C, Sawchuk R.: Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics. Anesthesiology 1995, 82:1269-1278
32. Davidkova T, Kikuchi H, Fujii K, Mukaida K, Sato N, Kawachi S, Morio M: Biotransformation of isoflurane: urinary and serum fluoride ion and organic fluorine. Anesthesiology 1988, 69:218-222
33. Zager RA, Bredl CR, Schimpf BA: Direct amphotericin B-mediated tubular toxicity: assessments of selected cytoprotective agents, Kidney Int 1992, 41:1588-1594
34. Garza-Quintero R, Weinberg JM, Ortega-Lopez J, Davis JA, Venkatachalam MA: Conservation of structure of ATP depleted proximal tubules: role of calcium, polyphosphoinositides, and glycine. Am J Physiol 1992, 265:F605-623
35. +-ATPase in brush border and basolateral membranes of rat kidney. Biol Pharm Bull 1995, 18:273-278
36. Dominguez JH, Garcia JG, Rothrock JK, English D, Mann C: Fluoride mobilizes intracellular calcium and promotes calcium influx in rat proximal tubules. Am J Physiol 1991, 261:F318-F327
37. Kawase T, Ishikawai I, Susuki A: The calcium mobilizing action of low concentrations of sodium fluoride in single fibroblasts. Life Sci 1988, 43:1253-1257